Monday, October 6, 2025

ENDRA Life Sciences Granted Two U.S. Patents for Non-Invasive Fat Assessment to Support TAEUS(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease




News Story – QuoteMedia Market Data Solutions




Share: